Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Boron containing doai
Patent
1997-06-13
1999-03-02
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Boron containing doai
540145, 424 165, 424 9362, 534 10, 534 14, 534 15, 514410, A61K 3169, C07F 505
Patent
active
058771654
ABSTRACT:
The present invention covers boronated porphyrins containing multiple carborane cages which selectively accumulate in neoplastic tissue within the irradiation volume and thus can be used in cancer therapies such as boron neutron capture therapy and photodynamic therapy.
REFERENCES:
patent: 4348376 (1982-09-01), Goldenberg
patent: 4665897 (1987-05-01), Wong
patent: 4783529 (1988-11-01), Lavalee et al.
patent: 4824659 (1989-04-01), Hawthorne
patent: 4837221 (1989-06-01), Bonnett et al.
patent: 4959356 (1990-09-01), Miura et al.
patent: 4992257 (1991-02-01), Bonnett et al.
patent: 5149801 (1992-09-01), Kahl et al.
patent: 5194603 (1993-03-01), Tsuchida et al.
patent: 5236914 (1993-08-01), Meunier et al.
patent: 5252698 (1993-10-01), Bhardwaj et al.
patent: 5262532 (1993-11-01), Tweedle et al.
patent: 5284821 (1994-02-01), Kahl et al.
patent: 5284831 (1994-02-01), Kahl et al.
patent: 5314905 (1994-05-01), Pandey et al.
patent: 5663328 (1997-09-01), Ellis, Jr. et al.
patent: 5674467 (1997-10-01), Maier et al.
Miura et al.,, "Synthesis, Tissue Uptake, and Toxicity of a Nickel Tetracarboranylphenylporphyrin", Paper presented at 6th International Symposium in Neutron Capture Therapy for Cancer, Kobe, Japan (Oct. 31-Nov. 4, 1994).
Miura et al., "Synthesis and Spectroscopic Characterization of Octaacetic Acid Tetraphenylporphyrins", Inorganic Chemistry, 33(26)(1994).
Miura et al., "Biodistribution and Toxicity of 2,4-Divinly-Nido-.sigma.-Carboranyldeuteroporphyrin IX in Mice", Biochemical Pharmacology, 43(3), pp. 467-.music-sharp.(1992).
Miura et al., "Preparation of Carboranyl Porphyrins for Boron Neutron Capture Therapy", Tetrahedron Letters, 31(16), pp. 2247-2250 (1990).
Chiusoli et al., "Synthesis of Pyrrole-3,4-diacetic Acid and Its Derivatives", Synthesis, pp. 262-265 (1989).
Coderre et al., "Boron Neutron Capture Therapy of Glioblastoma Multiforme Using p-boronophenylalanine and Epithermal Neutrons: Trial Design and Early Clinical Results", J. NeuroOncol 33pp. 141-152 (1997).
Coderre et al., "Selective Delivery of Boron by the Melanin Precursor Analogue pboronophenylalanine to Tumors Other Than Melanoma", Cancer Res., 50, pp. 138-141 (1990).
Fairchild et al., "Microanalytical Techniques for Boron Analysis Using the .sup.10 B(n,.alpha.).sup.7 Li reaction", Med. Phys., 13, pp. 50-56 (1986).
Miura et al., "Synthesis of a Nickel Tetracarboranylphenylporphyrin for Boron Neutron-Caputure Therapy: Biodistribution and Toxicity in Tumor-Bearing Mice", Int. J. Cancer: 68, pp. 114-119 (1996).
Oenbrink et al., "Accumulation of Porphyrins in Cells: Influence of Hydrophobicity, Aggregation and Protein Binding", Photochem. Photobiol., 48, pp. 451-456 (1988).
Slatkin et al., "Biodistribution and Toxicity of 2,4-Divinly-Nido-.omicron.-Carboranyl-Deuteroporphyrin IX in Mice, Erratum", Biochem. Pharm., 50, pp. 893-894 (1995).
Miura Michiko
Shelnutt John A.
Slatkin Daniel N.
Bogosian Margaret C.
Brookhaven Science Associates
Shah Mukund J.
Sripada Pavanaram K.
LandOfFree
Boronated porhyrins and methods for their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Boronated porhyrins and methods for their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Boronated porhyrins and methods for their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-423020